The molecular mechanism through which rapamycin inhibits the growth and proliferation of oral and oropharyngeal squamous cell carcinoma may lie in the inhibition of the PI3K/Akt/mTOR signalling pathway. Here, MTOR is linked to oropharynx squamous cell carcinoma.